Clinical Trial Update: Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD) [Phase 4]

View source ↗

Summary

Phase 4 trial investigating renoprotection with pentoxifylline in combination with an angiotensin receptor blocker for chronic kidney disease. The current statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Angiotensin receptor blocker (angiotensin receptor blocker)
• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Chronic Renal Failure | Phase 4 | Status: UNKNOWN